All In Biotech

Free tool

FAERS Monitor: Siklos

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208843 or its brand name (Siklos, Hydroxyurea). Reports on generic versions are filed under their own applications.

Reports

15,166

Serious

10,933

72% of reports

Hospitalization

5,380

Death reported

2,105

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,798
  • sickle cell anaemia with crisis1,320
  • fatigue1,174
  • diarrhoea1,118
  • nausea1,014
  • headache841
  • death786
  • product dose omission issue775
  • drug ineffective748
  • haemoglobin decreased688
  • anaemia678
  • pain666
  • pyrexia602
  • dyspnoea594
  • asthenia569

Reports by year received

View as table
YearReports
200491
200599
2006141
2007140
2008141
2009151
2010187
2011251
2012340
2013220
2014379
2015466
2016725
2017877
20181,091
2019974
20201,273
20211,484
20221,623
20231,508
20241,194
20251,071
2026740

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,038,993 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sickle cell anaemia with crisisSignal1,320126.7120.0150,814
haemoglobin decreasedSignal6889.38.75,112
anaemiaSignal6784.94.62,141
product dose omission issueSignal7753.73.41,514
off label useSignal1,7982.92.72,249
pyrexiaSignal6022.42.2505
diarrhoeaSignal1,1182.42.3943
astheniaSignal5692.11.9332
fatigueSignal1,1742.12.0694
headache8411.91.7344
nausea1,0141.81.7357
pain6661.51.4115
dyspnoea5941.51.387
death7861.31.245
drug ineffective7480.80.746

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.